ZA915937B - Tricyclic heterocyclic derivatives - Google Patents

Tricyclic heterocyclic derivatives

Info

Publication number
ZA915937B
ZA915937B ZA915937A ZA915937A ZA915937B ZA 915937 B ZA915937 B ZA 915937B ZA 915937 A ZA915937 A ZA 915937A ZA 915937 A ZA915937 A ZA 915937A ZA 915937 B ZA915937 B ZA 915937B
Authority
ZA
South Africa
Prior art keywords
heterocyclic derivatives
tricyclic heterocyclic
tricyclic
derivatives
heterocyclic
Prior art date
Application number
ZA915937A
Other languages
English (en)
Inventor
Roger John Butlin
John Butlin Roger
Dickson Glarvey
Glarvey Dickson
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA915937B publication Critical patent/ZA915937B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA915937A 1990-08-16 1991-07-29 Tricyclic heterocyclic derivatives ZA915937B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909018044A GB9018044D0 (en) 1990-08-16 1990-08-16 Tricyclic heterocyclic derivatives

Publications (1)

Publication Number Publication Date
ZA915937B true ZA915937B (en) 1992-04-29

Family

ID=10680792

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915937A ZA915937B (en) 1990-08-16 1991-07-29 Tricyclic heterocyclic derivatives

Country Status (14)

Country Link
EP (1) EP0471516A1 (cs)
JP (1) JPH04257563A (cs)
KR (1) KR920004352A (cs)
AU (1) AU8142291A (cs)
CA (1) CA2048298A1 (cs)
CS (1) CS251091A3 (cs)
FI (1) FI913893L (cs)
GB (2) GB9018044D0 (cs)
HU (1) HUT58293A (cs)
IE (1) IE912616A1 (cs)
IL (1) IL99075A0 (cs)
NO (1) NO913187L (cs)
PT (1) PT98680A (cs)
ZA (1) ZA915937B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7145396A (en) * 1995-10-04 1997-04-28 Eisai Co. Ltd. Acridone compounds
US6063921A (en) * 1997-11-20 2000-05-16 Pharm-Eco Laboratories, Inc. Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
WO2002020500A2 (en) 2000-09-01 2002-03-14 Icos Corporation Materials and methods to potentiate cancer treatment
CA2523178C (en) * 2003-03-24 2012-10-23 Luitpold Pharmaceuticals, Inc. Materials and methods to potentiate cancer treatment
EP2130817B1 (en) 2008-06-05 2016-01-06 AGFA Graphics NV Polymerizable Type II photoinitiators and curable compositions
US11866412B1 (en) 2023-03-03 2024-01-09 King Faisal University Acridin-9-one compounds as antibacterial agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH498841A (fr) * 1967-07-13 1970-11-15 Inst Farmaceutyczny Procédé de préparation de benzo-(b,1,8)-naphtyridones-5 substituées
DE2759468A1 (de) * 1977-08-29 1979-06-07 Sterling Drug Inc Acridinonverbindungen und ihre herstellung

Also Published As

Publication number Publication date
HUT58293A (en) 1992-02-28
EP0471516A1 (en) 1992-02-19
KR920004352A (ko) 1992-03-27
IL99075A0 (en) 1992-07-15
NO913187D0 (no) 1991-08-15
HU912511D0 (en) 1992-01-28
FI913893A7 (fi) 1992-02-17
FI913893A0 (fi) 1991-08-16
PT98680A (pt) 1992-08-31
GB9116779D0 (en) 1991-09-18
AU8142291A (en) 1992-02-20
IE912616A1 (en) 1992-02-26
CS251091A3 (en) 1992-03-18
FI913893L (fi) 1992-02-17
JPH04257563A (ja) 1992-09-11
CA2048298A1 (en) 1992-02-17
GB9018044D0 (en) 1990-10-03
NO913187L (no) 1992-02-17

Similar Documents

Publication Publication Date Title
GB2247017B (en) Rapamycin derivatives
ZA91782B (en) New heterocyclic derivatives
GB9015879D0 (en) Benzodiazepine derivatives
EP0438690A3 (en) Substituted pyrazolin derivatives
HU9300488D0 (en) Tricyclic benzodiazepine derivatives
IL104200A0 (en) Heterocyclic derivatives
GB9125842D0 (en) Heterocyclic derivatives
HU9400731D0 (en) Tricyclic heterocyclic compound
GB9102804D0 (en) Heterocyclic derivatives
GB9201789D0 (en) Heterocyclic derivatives
ZA916427B (en) Tricyclic pyridone derivatives
IL99075A0 (en) Tricyclic heterocyclic derivatives
GB9202633D0 (en) Heterocyclic derivatives
EP0519370A3 (en) Heterocyclic derivatives
GB9116571D0 (en) Tricyclic heterocyclic derivatives
GB9109545D0 (en) Tricyclic heterocyclic derivatives
GB9021855D0 (en) Tricyclic derivatives
GB9015486D0 (en) Heterocyclic derivatives
ZA917228B (en) Heterocyclic derivatives
GB9116572D0 (en) Tricyclic heterocyclic amine derivatives
ZA923958B (en) Heterocyclic derivatives
GB9106956D0 (en) Heterocyclic derivatives
GB9103874D0 (en) Heterocyclic derivatives
GB9124345D0 (en) Heterocyclic derivatives
GB9126294D0 (en) Heterocyclic derivatives